170 related articles for article (PubMed ID: 9637257)
21. The rate-limiting steps for the folding of an antibody scFv fragment.
Jäger M; Plückthun A
FEBS Lett; 1997 Nov; 418(1-2):106-10. PubMed ID: 9414105
[TBL] [Abstract][Full Text] [Related]
22. Triabodies: single chain Fv fragments without a linker form trivalent trimers.
Iliades P; Kortt AA; Hudson PJ
FEBS Lett; 1997 Jun; 409(3):437-41. PubMed ID: 9224705
[TBL] [Abstract][Full Text] [Related]
23. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
[TBL] [Abstract][Full Text] [Related]
24. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent--application to a human single-chain Fv fragment.
Tsumoto K; Shinoki K; Kondo H; Uchikawa M; Juji T; Kumagai I
J Immunol Methods; 1998 Oct; 219(1-2):119-29. PubMed ID: 9831393
[TBL] [Abstract][Full Text] [Related]
25. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
26. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
27. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
28. Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency.
Rivera-Hernández G; Marin-Argany M; Blasco-Moreno B; Bonet J; Oliva B; Villegas S
MAbs; 2013; 5(5):678-89. PubMed ID: 23924802
[TBL] [Abstract][Full Text] [Related]
29. Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus.
Cai K; Wang H; Bao S; Shi J; Hou X; Gao X; Liu H; Yin J
Microbes Infect; 2008 Apr; 10(5):548-55. PubMed ID: 18424153
[TBL] [Abstract][Full Text] [Related]
30. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
[TBL] [Abstract][Full Text] [Related]
31. Expression in Escherichia coli of soluble and M13 phage-displayed forms of a single-chain antibody fragment specific for digoxin: assessment in a novel drug immunoassay.
Navarro-Teulon I; Peraldi-Roux S; Bernardi T; Marin M; Piechaczyk M; Shire D; Pau B; Biard-Piechaczyk M
Immunotechnology; 1995 May; 1(1):41-52. PubMed ID: 9373332
[TBL] [Abstract][Full Text] [Related]
32. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
[TBL] [Abstract][Full Text] [Related]
33. Engineered recombinant single-chain fragment variable antibody for immunosensors.
Shen Z; Mernaugh RL; Yan H; Yu L; Zhang Y; Zeng X
Anal Chem; 2005 Nov; 77(21):6834-42. PubMed ID: 16255580
[TBL] [Abstract][Full Text] [Related]
34. [Recombinant design and expression of human three-domain antibody against BoNTa].
Wang H; Yin J; Shi J; Meng LL; Li PZ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):223-5. PubMed ID: 15989265
[TBL] [Abstract][Full Text] [Related]
35. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.
Kipriyanov SM; Moldenhauer G; Martin AC; Kupriyanova OA; Little M
Protein Eng; 1997 Apr; 10(4):445-53. PubMed ID: 9194170
[TBL] [Abstract][Full Text] [Related]
36. Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase.
Atwell JL; Pearce LA; Lah M; Gruen LC; Kortt AA; Hudson PJ
Mol Immunol; 1996 Dec; 33(17-18):1301-12. PubMed ID: 9171890
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
38. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Heymann S; Little M
Cell Biophys; 1995 Jun; 26(3):187-204. PubMed ID: 8521451
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region.
Hagihara Y; Mine S; Uegaki K
J Biol Chem; 2007 Dec; 282(50):36489-95. PubMed ID: 17932041
[TBL] [Abstract][Full Text] [Related]
40. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
Ohage EC; Wirtz P; Barnikow J; Steipe B
J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
